Benefit from adjuvant radiotherapy in early-stage oral cavity and oropharyngeal cancer with solitary ipsilateral lymph node metastasis – A population-based study on German cancer registry data

This clinical cancer registry study portends an oncological benefit of adjuvant RT for patients with early-stage (pT1/pT2) OSCC and p16-negative OPSCC who present with solitary ipsilateral lymph node metastasis. This benefit was particularly notable in the sub-cohort of younger patients with p16-negative OPSCC and the sub-cohort of elderly patients with OSCC.

Authors

Institutions

Publication Details

Journal
Oral Oncology
Published
2025-06-02
DOI
https://doi.org/10.1016/j.oraloncology.2025.107384
Citations
7
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
12.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Benefit from adjuvant radiotherapy in early-stage oral cavity and oropharyngeal cancer with solitary ipsilateral lymph node metastasis – A population-based study on German cancer registry data

Daniel Zips, Ian Wittenberg, Andrea Sackmann, Christian Doll et al.
7 citations
Oral Oncology
Head and Neck Cancer Studies
12.94
article

Benefit from adjuvant radiotherapy in early-stage oral cavity and oropharyngeal cancer with solitary ipsilateral lymph node metastasis – A population-based study on German cancer registry data

Daniel Zips, Ian Wittenberg, Andrea Sackmann, Christian Doll, Steffen Dommerich, Anne Letsch, Anna Trelinska-Finger, Fabian Reinwald, Barbara Franke, Marcus Beck, Ingeborg Tinhofer, Sylke Ruth Zeißig, Elena Hofmann, Maren Knödler, Konrad Klinghammer, Monika Klinkhammer‐Schalke, Max Heiland, Kerstin Weitmann, Constanze Schneider
article en
7 citations

Abstract

This clinical cancer registry study portends an oncological benefit of adjuvant RT for patients with early-stage (pT1/pT2) OSCC and p16-negative OPSCC who present with solitary ipsilateral lymph node metastasis. This benefit was particularly notable in the sub-cohort of younger patients with p16-negative OPSCC and the sub-cohort of elderly patients with OSCC.

Oral OncologyVol. 167
Hess (United States) (US), University of Würzburg (DE), Universitätsmedizin Greifswald (DE), Humboldt-Universität zu Berlin (DE), German Cancer Society (DE), Experimental Factory Magdeburg (DE), NHS Digital (GB), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Brandenburg University of Technology Cottbus-Senftenberg (DE), Charité - Universitätsmedizin Berlin (DE)
Good health and well-being
Openalex Percentile: Top 1%
Head and Neck Cancer Studies
12.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.